FDA/DEA Ban Of Andro Sought By Blue Cross & Blue Shield Foundation
This article was originally published in The Tan Sheet
Executive Summary
A youth sports advocacy group is attempting to halt the sale and use of androstenedione-containing dietary supplements with a dual-pronged initiative aimed at Major League Baseball players and federal regulators, including FDA.
You may also be interested in...
Sports Supplement Steroid Metabolites Targeted By AMA
The American Medical Association will urge Congress to develop and enact legislation declaring anabolic steroid metabolites and precursors as drug substances not suitable for use in dietary supplements.
White House Sports Drug Task Force Preliminary Report Expected Early 2001
Sports nutritional supplements such as androstenedione and ephedrine, which are banned in international Olympic competition but legally available in the U.S., could be subjected to new scrutiny by a national task force on performance-enhancing substances.
Andro
Sports supplement will be classified as a steroid in the coming months, Drug Czar Barry McCaffrey announces at a Citizenship Through Sports Alliance meeting in Arlington, Va. June 26. President Clinton's top drug policy adviser maintains androstenedione fits the criteria to be labeled a steroid in two of the three government tests used to classify hormonal substances. Groups such as the Blue Cross/Blue Shield's Healthy Competition Foundation have asked pro athletes to stop using performance enhancing substances, which gained notoriety due to their use by popular stars such as baseball slugger Mark McGwire, who has since stopped using andro (1"The Tan Sheet" April 3, p. 6)